Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through ...

Cai et al. report gate-injection-mode floating-gate memories based on MoS2 channel. The coplanar device design and bi-pulse state programming enable 8-bit conductance states at 3 V. Image ...

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug. The deal means ...

After hours: March 17 at 7:28:04 PM EDT Loading Chart for VRTX ...

Immune cells called natural killer cells can target and eliminate tumours. The gene expression and spatial distribution of the immune cells in the tumour microenvironment indicates whether liver ...